Clinical Innovations establishes new subsidiary in China

Clinical Innovations, a medical device firm focused on labor and delivery and neonatal intensive care has established CI Medical Instruments in China.

Image: Chinese flag. Photo: Courtesy of Gary Tamin/FreeImages.com

Subscribe to our email newsletter

The creation of the new wholly owned subsidiary, headquartered in Shanghai, marks a strategic acceleration of Clinical Innovations’ global growth strategy.

Clinical Innovations CEO and president Ken Reali said: “With our mission of helping mothers and babies around the world, it’s critical we continue expanding in regions where we can have a big impact. China is an important, underserved market, and we look forward to meeting its needs with an organization that puts clinicians and families first.”

With its market-leading devices already used in more than 90 countries, Clinical Innovations has been expanding internationally, acquiring Australian company JB Medical Supplies in June and German company Brenner Medical GmbH in summer 2017.

Clinical Innovations has also entered underserved markets in Asia, including China. CI Medical Instruments will allow the company to strengthen its presence and operations in the country.

Leading the new effort will be Kevin Han, an executive with deep experience building distribution channels and business operations in China for international health care companies.

A native of China, Han most recently built Boston Scientific’s Chinese Urology and Pelvic Health unit from the ground up. In earlier roles, he led channel management in China for Johnson & Johnson Medical and GE China.

Clinical Innovations global sales senior vice president Steve Cash said “Creating CI Medical Instruments represents a major milestone for Clinical Innovations, and Kevin is the perfect person to spearhead this new venture. With the strategy, structure and leadership we have in place, there’s no limit to what we can achieve here and around the world.”

Founded in 1993 and based in Salt Lake City, Clinical Innovations is owned by EQT, a leading investment firm with approximately EUR 50 billion in raised capital across 27 funds. Clinical Innovations products include the ebb Complete Tamponade System, babyLance™ Safety heel stick and Kiwi® Vacuum-Assisted Delivery System.

Han, whose academic degrees include an executive MBA from the internationally recognized joint program of Fudan University and Washington University in St. Louis, begins his duties immediately.